Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

66 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Baseline MRI Visit 08 SirTac NCT02936388 - Baseline MRI Visit 08

- 26/11/17 - 1 formulario, 3 itemgroups, 20 items, 1 idioma
Itemgroups: Baseline MRI, location liver, Non-target Lesions
Study part: Baseline MRI Visit 08. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Baseline MRI Visit 06 SirTac NCT02936388 - Baseline MRI Visit 06

- 26/11/17 - 1 formulario, 3 itemgroups, 20 items, 1 idioma
Itemgroups: Baseline MRI, location liver, Non-target Lesions
Study part: Baseline MRI Visit 06. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Baseline MRI 12- Weeks Visits SirTac NCT02936388 - Baseline MRI 12- Weeks Visits

- 3/12/17 - 1 formulario, 3 itemgroups, 20 items, 1 idioma
Itemgroups: Baseline MRI, location liver, Non-target Lesions
Study part: Baseline MRI 12- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Baseline MRI 6- Weeks Visits SirTac NCT02936388 - Baseline MRI 6- Weeks Visits

- 3/12/17 - 1 formulario, 3 itemgroups, 20 items, 1 idioma
Itemgroups: Baseline MRI, location liver, Non-target Lesions
Study part: Baseline MRI 6- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Baseline MRI Screening Day -14 to 0 SirTac NCT02936388 - Baseline MRI Screening Day -14 to 0

- 26/11/17 - 1 formulario, 3 itemgroups, 13 items, 1 idioma
Itemgroups: Baseline MRI, location liver, Non-target Lesions
Study part: Baseline MRI Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Baseline MRI Screening Day -14 to 0 SirTac NCT02936388 - Baseline MRI Screening Day -14 to 0

- 20/11/17 - 1 formulario, 3 itemgroups, 13 items, 1 idioma
Itemgroups: Baseline MRI, location liver, Non-target Lesions
Study part: Baseline MRI Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Arm A / SIRT SirTac NCT02936388 - Arm A / SIRT

- 20/9/21 - 1 formulario, 3 itemgroups, 21 items, 1 idioma
Itemgroups: Diagnostic procedure, selective internal radiation therapy, Adverse Events
Study part: Arm A / SIRT. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 05 SirTac NCT02936388 - Laboratory Visit 05

- 31/1/22 - 1 formulario, 1 itemgroup, 29 items, 1 idioma
Itemgroup: Laboratory
Study part: Laboratory Visit 05. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 06 SirTac NCT02936388 - Laboratory Visit 06

- 31/1/22 - 1 formulario, 1 itemgroup, 29 items, 1 idioma
Itemgroup: Laboratory
Study part: Laboratory Visit 06. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 01 SirTac NCT02936388 - Laboratory Visit 01

- 31/1/22 - 1 formulario, 1 itemgroup, 29 items, 1 idioma
Itemgroup: Laboratory
Study part: Laboratory Visit 01. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory 6- Weeks Visits SirTac NCT02936388 - Laboratory 6- Weeks Visits

- 31/1/22 - 1 formulario, 1 itemgroup, 29 items, 1 idioma
Itemgroup: Laboratory
Study part: Laboratory 6- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 08 SirTac NCT02936388 - Laboratory Visit 08

- 31/1/22 - 1 formulario, 1 itemgroup, 29 items, 1 idioma
Itemgroup: Laboratory
Study part: Laboratory Visit 08. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial